跳至主要内容
临床试验/ACTRN12619000648123
ACTRN12619000648123已完成3 期

ignocaine versus opioids as analgesia in patients undergoing percutaneous coronary intervention and its pharmacokinetic and pharmacodynamic impacts on the antiplatelet activity of ticagrelor

Alfred Health0 个研究点目标入组 70 人开始时间: 2019年5月1日最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
Alfred Health
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Males and non-pregnant females over 18 years of age who have provided informed consent for angiography and PCI

排除标准

  • Out of hospital cardiac arrest
  • Cardiogenic shock
  • Morphine or opiate administration in the preceding 24 hours or regular use
  • Patients with a known coagulopathy or coagulation disorder
  • Allergy to fentanyl or lignocaine
  • Bradycardia or evidence of AV block
  • Ticagrelor or other P2Y12 inhibitor use in the preceding 10 days

研究者

发起方
Alfred Health

相似试验